跳至主要内容
临床试验/NCT02150720
NCT02150720已完成3 期

Prevention of Postoperative Bleeding in Femoral Fractures: a Multicenter, Randomized, Controlled, Parallel Clinical Trial to Assess the Efficacy of Tranexamic Acid and Fibrin Glue

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau6 个研究点 分布在 1 个国家目标入组 161 人开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
161
试验地点
6
主要终点
Blood loss (ml) after surgery

研究概览

简要总结

The main hypothesis of this clinical trial is that the use of intra-articular tranexamic acid and the fibrin glue plus usual hemostasis will reduce at least a 25% the postoperative blood loss with respect to usual hemostasis in patients undergoing subcapital femoral fractures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years
  • Patients with unilateral subcapital femoral fracture
  • Patients requiring hip replacement (total or partial)
  • Signed informed consent from the patient or legal representative

排除标准

  • Known allergy to fibrin glue and tranexamic acid
  • Multiple fractures
  • Pathological fractures
  • Contraceptives or estrogen therapy
  • Use of blood salvage during surgery
  • History compatible with thromboembolic disease:
  • Cerebral vascular accident
  • Ischemic heart disease (myocardial infarction, angina )
  • Deep vein thrombosis
  • Pulmonary Embolism
  • Peripheral arterial vasculopathy
  • Patients with thrombogenic arrhythmias
  • Patients with cardiovascular stents
  • Prothrombotic alterations in coagulation

研究组 & 干预措施

Fibrin glue

Experimental

One intra-articular dose of fibrin glue (Evicel 5mL) before closing the wound surgery,

干预措施: Fibrin glue (Drug)

Tranexamic acid

Experimental

Tranexamic acid, 1g intra-articular before closing the surgery wound

干预措施: Tranexamic Acid (Drug)

Tranexamic acid

Experimental

Tranexamic acid, 1g intra-articular before closing the surgery wound

干预措施: Electrocauterization (Procedure)

Fibrin glue

Experimental

One intra-articular dose of fibrin glue (Evicel 5mL) before closing the wound surgery,

干预措施: Electrocauterization (Procedure)

Usual hemostasia

Active Comparator

Electrocauterization

干预措施: Electrocauterization (Procedure)

结局指标

主要结局

Blood loss (ml) after surgery

时间窗: The first postoperative 24h

The blood lost from the wound will be collected by a drainage system during the first 24 hours postoperatively.

次要结局

  • Hidden blood loss(The first postoperative five days)
  • Proportion of patients requiring blood transfusion(The first postoperative ten days)
  • Units of blood transfused(The first postoperative ten days)
  • Proportion of patients with wound infection(The first postoperative month)
  • Proportion of patients with wound dehiscence(The first postoperative month)
  • Deep venous thrombosis(The first postoperative ten days)
  • Length of hospital stay(The first postoperative ten days)
  • Quality of life measured with the generic EQ-5D -5L(Preoperatively, at 5 days postoperatively , 1-2, 6 and 12 months postoperative follow-up)
  • Mortality(During the 12 month of follow-up after surgery)
  • Direct cost(During the first postoperative month)

研究者

发起方
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验